Evaluation of proliferation and apoptosis markers in circulating tumor cells of women with early breast cancer who are candidates for tumor dormancy

por Spiliotaki, Maria, Mavroudis, Dimitris, Kapranou, Kyriaki, Markomanolaki, Harris, Kallergi, Galatea, Koinis, Filippos, Kalbakis, Kostas, Georgoulias, Vassilis, Agelaki, Sofia
Publicado 2014

Efficacy of Lapatinib in Therapy-Resistant HER2-Positive Circulating Tumor Cells in Metastatic Breast Cancer

por Agelaki, Sofia, Kalykaki, Antonia, Markomanolaki, Harris, Papadaki, Maria A., Kallergi, Galatea, Hatzidaki, Dora, Kalbakis, Kostas, Mavroudis, Dimitrios, Georgoulias, Vassilis
Publicado 2015

Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse

por Saloustros, Emmanouil, Perraki, Maria, Apostolaki, Stella, Kallergi, Galatea, Xyrafas, Alexandros, Kalbakis, Kostas, Agelaki, Sophia, Kalykaki, Antonia, Georgoulias, Vassilis, Mavroudis, Dimitris
Publicado 2011

Detection of circulating tumour cells before and following adjuvant chemotherapy and long-term prognosis of early breast cancer

por Matikas, Alexios, Kotsakis, Athanasios, Apostolaki, Stella, Politaki, Helen, Perraki, Maria, Kalbakis, Kostas, Nikolaou, Michalis, Economopoulou, Panagiota, Hatzidaki, Dora, Georgoulias, Vassilis
Publicado 2022

Skin and Soft Tissue Infections in Patients with Solid Tumours

por Kofteridis, Diamantis P., Valachis, Antonios, Koutsounaki, Eirini, Maraki, Sofia, Mavrogeni, Eleni, Economidou, Foteini N., Dimopoulou, Dimitra, Kalbakis, Kostas, Georgoulias, Vassilis, Samonis, George
Publicado 2012

Central nervous system relapse in patients with breast cancer is associated with advanced stages, with the presence of circulating occult tumor cells and with the HER2/neu status

por Souglakos, John, Vamvakas, Lambros, Apostolaki, Stella, Perraki, Maria, Saridaki, Zacharenia, Kazakou, Irine, Pallis, Athanasios, Kouroussis, Charalambos, Androulakis, Nikos, Kalbakis, Kostas, Millaki, Georgia, Mavroudis, Dimitris, Georgoulias, Vassilis
Publicado 2006

Nab-paclitaxel as second-line treatment in advanced gastric cancer: a multicenter phase II study of the Hellenic Oncology Research Group

por Katsaounis, Panagiotis, Kotsakis, Athanasios, Kentepozidis, Nikolaos, Polyzos, Aris, Bakogeorgos, Marios, Koinis, Filippos, Vamvakas, Lambros, Vardakis, Nikolaos, Kalbakis, Kostas, Boukovinas, Ioannis, Varthalitis, Ioannis I., Prinarakis, Efthimios, Georgoulias, Vassilis, Souglakos, John
Publicado 2018

Front-line Bevacizumab in combination with Oxaliplatin, Leucovorin and 5-Fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study

por Emmanouilides, Christos, Sfakiotaki, Georgia, Androulakis, Nikolaos, Kalbakis, Kostas, Christophylakis, Charalambos, Kalykaki, Antonia, Vamvakas, Lambros, Kotsakis, Athanasios, Agelaki, Sofia, Diamandidou, Eleni, Touroutoglou, Nikolaos, Chatzidakis, Adam, Georgoulias, Vassilis, Mavroudis, Dimitris, Souglakos, John
Publicado 2007

Front-Line Bevacizumab plus Chemotherapy with or without Maintenance Therapy for Metastatic Breast Cancer: An Observational Study by the Hellenic Oncology Research Group

por Kokkali, Stefania, Saloustros, Emmanouil, Stefanou, Dimitra, Makrantonakis, Paris, Kentepozidis, Nikolaos, Boukovinas, Ioannis, Xenidis, Nikolaos, Katsaounis, Panagiotis, Ardavanis, Alexandros, Ziras, Nikolaos, Christopoulou, Athina, Rigas, George, Kalbakis, Kostas, Vardakis, Nikolaos, Emmanouilides, Christos, Athanasiadis, Ilias, Anagnostopoulos, Athanassios, Hatzidaki, Dora, Prinarakis, Efthimios, Simopoulou, Foteini, Kotsakis, Athanasios, Georgoulias, Vassilis
Publicado 2022